These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3120204)

  • 1. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.
    de Villiers AS; Russell VA; Carstens ME; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1987 Oct; 22(2):127-40. PubMed ID: 3120204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in adolescents with major depressive disorder.
    de Villiers AS; Russell VA; Carstens ME; Searson JA; van Zyl AM; Lombard CJ; Taljaard JJ
    Psychiatry Res; 1989 Feb; 27(2):101-9. PubMed ID: 2710859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.
    Roy A; Pickar D; De Jong J; Karoum F; Linnoila M
    Arch Gen Psychiatry; 1988 Sep; 45(9):849-57. PubMed ID: 3415426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL; Price LH; Charney DS; Heninger GR
    Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic function and the dexamethasone suppression test in depression.
    Morinobu S; Satoh H; Endoh M; Totsuka S
    Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
    Werstiuk ES; Coote M; Griffith L; Shannon H; Steiner M
    Br J Psychiatry; 1996 Dec; 169(6):758-65. PubMed ID: 8968635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading.
    Maes M; Vandevelde R; Suy E
    J Affect Disord; 1989; 17(2):173-82. PubMed ID: 2549110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.
    Maes M; Minner B; Suy E; Vandervorst C; Raus J
    J Neural Transm Gen Sect; 1991; 85(3):195-210. PubMed ID: 1930881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic tests in depression.
    Roy A; Pickar D; Paul S
    Psychosomatics; 1984 Jun; 25(6):443-7, 451. PubMed ID: 6204353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma MHPG, peripheral noradrenergic marker and hormonal plasma levels of cortisol-T3-T4-TSH in depressive syndromes].
    Bottai T; Levy C; Lancon C; Azorin JM; Grignon S; Valli M; Jadot G; Tissot R
    Encephale; 1991; 17(3):203-11. PubMed ID: 1864254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.
    Sevy S; Papadimitriou GN; Surmont DW; Goldman S; Mendlewicz J
    Biol Psychiatry; 1989 Jan; 25(2):141-52. PubMed ID: 2539200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indices of noradrenergic output in depression.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL
    Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process.
    Maes M; Bosmans E; Suy E; Minner B; Raus J
    Br J Psychiatry; 1989 Dec; 155():793-8. PubMed ID: 2620206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol response to dexamethasone and noradrenergic function in depression.
    Maes M; de Ruyter M; Suy E
    Acta Psychiatr Scand; 1987 Feb; 75(2):171-5. PubMed ID: 3565061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin releasing hormone test in unipolar depressed patients and controls: relationship to clinical and biologic variables.
    Roy A; Karoum F; Linnoila M; Pickar D
    Acta Psychiatr Scand; 1988 Feb; 77(2):151-9. PubMed ID: 3129906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine.
    Price LH; Charney DS; Rubin AL; Heninger GR
    Arch Gen Psychiatry; 1986 Sep; 43(9):849-58. PubMed ID: 3019271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-free and sulfoconjugated MHPG in major depressive disorders: differences between responders to treatment and nonresponders.
    Mine K; Okada M; Mishima N; Fujiwara M; Nakagawa T
    Biol Psychiatry; 1993 Nov; 34(9):654-60. PubMed ID: 8292695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.